Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

7,994 public trials 713 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients

NCT01476475

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Investigational Site Number 840408 Little Rock, Arkansas, United States
  • Investigational Site Number 840412 Paramount, California, United States
  • Investigational Site Number 840401 Larenceville, Georgia, United States
  • Investigational Site Number 840417 Roswell, Georgia, United States
View all 70 locations
View Trial Details
Completed

A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes

NCT01665352

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Site 18 Chula Vista, California, United States
  • Site 1 Los Angeles, California, United States
  • Site 13 Denver, Colorado, United States
  • Site 4 Coral Gables, Florida, United States
View all 19 locations
View Trial Details
Completed

Comparison of the Blood Sugar Lowering Effect Between Repaglinide Plus Metformin and Repaglinide Alone in Type 2 Diabetics Not Previously Treated With Oral Sugar-lowering Drugs

NCT00819741

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Fuzhou, Fujian, China
  • Novo Nordisk Investigational Site Nanjing, Jiangsu, China
  • Novo Nordisk Investigational Site Nanjing, Jiangsu, China
  • Novo Nordisk Investigational Site Nanjing, Jiangsu, China
View all 17 locations
View Trial Details
Completed

Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment

NCT00663260

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Vista Medical Research, Inc. Mesa, Arizona, United States
  • Valley Research Fresno, California, United States
  • Marin Endocrine Care & Research, Inc. Greenbrae, California, United States
  • Office Of Richard Cherlin, Md Los Gatos, California, United States
View all 96 locations
View Trial Details
Completed

A Trial Investigating the Efficacy and Safety of Flexible vs. Fixed Dosing and Simple vs. Stepwise Titration With Once Daily (OD) Insulin Degludec in Inadequately Treated Subjects With Type 2 Diabetes

NCT01880736

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan
  • Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan
  • Novo Nordisk Investigational Site Fukui-shi, Fukui, Japan
  • Novo Nordisk Investigational Site Fukuoka, Japan
View all 40 locations
View Trial Details

Related conditions